Menopause Care

HRT Benefits and Risks: What the Research Actually Shows

April 2026 · 5 min read

Hormone replacement therapy has one of the most misunderstood reputations in women's medicine. Many women who could benefit from it are afraid of it, and many doctors who could prescribe it don't. Understanding what the research actually says — rather than what the 2002 Women's Health Initiative headlines led people to believe — is the first step toward making an informed decision.

What HRT actually does

HRT supplements the hormones your body produces at lower and lower levels during perimenopause and menopause. The primary hormones involved are estrogen (usually estradiol), progesterone, and sometimes testosterone. By restoring these hormones to levels closer to pre-menopausal norms, HRT can relieve hot flashes, night sweats, sleep disruption, vaginal dryness, mood changes, and loss of libido. It also protects bone density and, in some studies, reduces cardiovascular risk when started early.

The 2002 study that scared everyone

The Women's Health Initiative study in 2002 found increased risks of breast cancer, stroke, and heart disease in women taking a specific combination of oral conjugated estrogens and medroxyprogesterone acetate. The results were reported in a way that alarmed the public and triggered a massive drop in HRT prescriptions that has only partially recovered two decades later.

What the headlines missed is that the average age of participants in that study was 63 — more than a decade past menopause onset — and that the specific formulations used are rarely prescribed today. Subsequent analysis and more recent studies have shown that the risk-benefit profile looks very different when HRT is started within 10 years of menopause onset, and when it uses modern formulations like transdermal estradiol and micronized progesterone.

The risks in modern context

Modern HRT does carry real risks, which vary by formulation, timing, and individual health history. For most women under 60 who start within 10 years of menopause, the absolute increase in risk for events like breast cancer is small and the quality-of-life benefits are large. Transdermal estrogen (patches, gels, sprays) avoids first-pass liver metabolism and carries a lower risk profile for blood clots than oral estrogen. Micronized progesterone has a better safety profile than older synthetic progestins.

HRT is not appropriate for every woman. A personal history of breast cancer, unexplained vaginal bleeding, active liver disease, or recent blood clots are among the contraindications your physician will screen for.

Who benefits most

The women who see the biggest quality-of-life improvements are typically those with moderate-to-severe vasomotor symptoms (hot flashes and night sweats), sleep disruption, genitourinary symptoms, and mood changes that began around the menopause transition. Women with premature or early menopause — before age 45 — are typically advised to continue HRT until the average age of natural menopause, because the risks of not having adequate hormone levels outweigh the risks of supplementation at those ages.

The bottom line

HRT is a medical decision, not a lifestyle accessory. It has real benefits and real risks, and the right answer depends on your symptoms, your history, and your goals. What it shouldn't be is a decision made out of fear based on outdated headlines, or a decision denied to you because a provider hasn't updated their training.

Read next: 10 Signs of Perimenopause Most Women Ignore · GLP-1 Medication for Women: What to Expect Month by Month · Main topic: Menopause Care